A new study published in Endocrine-Related Cancer which used data from the OCRF-funded Ovarian Cancer Association Consortium, evaluated the association between BMI and ovarian cancer risk, and also examined the association by … Continued
The University of Texas MD Anderson Cancer Center is one of the nation’s preeminent hospitals for cancer care. Located in Houston, Texas, MD Anderson’s Blanton-Davis Ovarian Cancer Research Program was … Continued
A new report from the American Cancer Society estimates cancer incidence and mortality rates for African Americans. In the case of ovarian cancer, both incidence and mortality are lower for … Continued
A new study of mice with prostate cancer indicated that stress can hinder the effectiveness of anti-cancer therapies. In this mouse model, the use of beta-blockers did prevent stress from … Continued
In the journal Clinical Cancer Research, a group of researchers, including current and past OCRF grantees Anil Sood and Gabriel Lopez-Berestein, evaluated the prognostic value of fibroblast growth factor receptor 4 (FGFR4) … Continued
A study of 425 Stage III and IV ovarian cancer patients had either primary debulking surgery or interval debulking surgery. Interval debulking surgery did not appear to increase the risk … Continued
In a study published in the American Journal of Clinical Nutrition, researchers from Curtin University in Australia found that extended breastfeeding significantly reduces the risk of ovarian cancer in women. The … Continued
A new study indicates a direct link between higher blood calcium levels and presence of ovarian cancer. Specifically, “women who were later diagnosed with ovarian cancer and women who later … Continued
A new approach to monitoring CA-125, using an algorithm that looks at its change over time, is more effective at identifying ovarian cancer earlier than using a single-threshold number.
In an analysis of more than 4,000 women with ovarian cancer, it appears that some hormonal and reproductive factors may affect tumor aggressiveness. The study showed that increased age was … Continued
A study of 149 women with platinum sensitive ovarian cancer, half treated with carboplatin and paclitaxel or gemcitabine, half with that treatment plus pertuzumab, showed that the addition of pertuzumab … Continued
OCRF receives record number of research grant applications; launches national patient support program with new educational grants New York, NY January 10, 2013 — Ovarian Cancer Research Fund (OCRF) has … Continued
Get email updates about research news, action alerts, and ways to join the fight.
